Venker Eric bought IMVT
April 7, 2026 · Form 4 insider transaction
Venker Eric bought 232,252 shares of Immunovant, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
232,252
Price
$0.00
Total value
N/A
InsiderVenker Eric
RoleOfficer
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after251,813
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the total shares on April 1, 2027 and the balance will vest in twelve (12) successive substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.